Conference Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

375 * ! Wed, 8/10/2022, 8:30 AM - 10:20 AM CC-203AB
Causal Estimand in Clinical Trials — Topic Contributed Papers
Biometrics Section, Biopharmaceutical Section, Health Policy Statistics Section
Organizer(s): Lei Nie, U. S. FDA
Chair(s): Frank Bretz, Novartis
8:35 AM Covariate Adjustment and Missing Data in Clinical Trials
Daniel Rubin, U.S. Food and Drug Administration
8:55 AM Estimating the Average Treatment Effect in Randomized Clinical Trials with All-or-None Compliance
Zhiwei Zhang, National Cancer Institute/National Institutes of Health; Zonghui Hu, National Institutes of Health; Dean Follmann, National Institute of Allergy and Infectious Diseases; Lei Nie, U. S. FDA
9:15 AM Estimands and Their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic
Kelly Van Lancker, Johns Hopkins University, Bloomberg School of Public Health, US and Ghent University, Belgium; Sergey Tarima, Division of Biostatistics, Medical College of Wisconsin; Jonathan Bartlett, University of Bath; Madeline Bauer, Division of Infectious Diseases, Keck School of Medicine, University of Southern Californi; Bharani Bharani-Dharan, Novartis Pharmaceuticals; Frank Bretz, Novartis; Nancy Flournoy, University of Missouri; Hege Michiels, Ghent University; Camila Olarte Parra, University of Bath; James Landis Rosenberger, Penn State and NISS; Suzie Cro, Imperial Clinical Trials Unit, Imperial College London
9:35 AM Discussant: Wanjie Sun, The US FDA
9:55 AM Discussant: Tianmeng Lyu, Novartis
10:15 AM Floor Discussion